EVOK - Evoke Pharma Inc

QQQ $ 482.88 $ 2.24 (0.47 %)

DIA $ 408.91 $ 0.43 (0.11 %)

SPY $ 560.81 $ 1.92 (0.34 %)

TLT $ 98.72 $ 0.06 (0.06 %)

GLD $ 232.16 $ -0.31 (-0.13 %)

Previous Close

$ 4.86

Open

Bid

$ 4.78 x 100

Ask

-- x --

Day's Range

-- - --

52 Week Range

$ 3.75 - $ 18.60

Volume

256,346

Average Volume

Market Cap

6.63M

Beta (5Y Monthly)

$ 0.73

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-14-2024	12-31-2023	10-K
4	11-09-2023	09-30-2023	10-Q
5	08-10-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-21-2023	12-31-2022	10-K
8	11-09-2022	09-30-2022	10-Q
9	08-10-2022	06-30-2022	10-Q
10	05-10-2022	03-31-2022	10-Q
11	03-08-2022	12-31-2021	10-K
12	11-10-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	05-12-2021	03-31-2021	10-Q
15	03-11-2021	12-31-2020	10-K
16	11-10-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-12-2020	03-31-2020	10-Q
19	03-12-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-08-2019	06-30-2019	10-Q
22	05-08-2019	03-31-2019	10-Q
23	03-06-2019	12-31-2018	10-K
24	11-13-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-14-2018	03-31-2018	10-Q
27	03-07-2018	12-31-2017	10-K
28	11-14-2017	09-30-2017	10-Q
29	08-14-2017	06-30-2017	10-Q
30	05-15-2017	03-31-2017	10-Q
31	03-15-2017	12-31-2016	10-K
32	11-09-2016	09-30-2016	10-Q
33	08-15-2016	06-30-2016	10-Q
34	05-11-2016	03-31-2016	10-Q
35	03-10-2016	12-31-2015	10-K
36	11-12-2015	09-30-2015	10-Q
37	08-13-2015	06-30-2015	10-Q
38	05-14-2015	03-31-2015	10-Q
39	03-04-2015	12-31-2014	10-K
40	11-13-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Evoke Pharma Shares Halted To The Downside...
08/20/2024 13:57:15

Evoke Pharma Q2 EPS $(0.93) Misses $(0.06)...
08/13/2024 12:23:31

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.93) per share which missed the analyst consensus estimate of $(0.06...

Trading Halt: Halted at 7:50:00 p.m. ET - ...
07/31/2024 23:50:04

Why Evoke Pharma (EVOK) Stock Is Volatile
07/30/2024 21:22:08

Evoke Pharma shares were trading lower by 21.4% during Tuesday's session. The company announced a 1-for-12 reverse stock sp...

Evoke Pharma Announces 1-For-12 Reverse St...
07/30/2024 12:31:54

Common Stock To Trade On Split-Adjusted Basis Under Symbol EVOK With New CUSIP 30049G302

Evoke Pharma Reports Commercial Strategy P...
06/17/2024 12:41:36

Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024Promoted former VP...

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
05/23/2024 20:31:02

Evoke Pharma Presents Additional GIMOTI He...
05/16/2024 20:22:13

Evoke Pharma, Inc.(NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) d...

Evoke Pharma Reiterates FY24 Net Revenue ~...
05/14/2024 20:55:35

Evoke Pharma Q1 2024 GAAP EPS $(0.17) Beat...
05/14/2024 20:54:31

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.21) ...

Evoke Pharma Announces Senior Leadership T...
03/21/2024 20:28:34

Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) ...

Evoke Pharma Sees FY24 Net Revenue ~$14M V...
03/14/2024 20:50:06

Recap: Evoke Pharma Q4 Earnings
03/14/2024 20:35:20

Evoke Pharma Q4 2023 GAAP EPS $(0.59) Miss...
03/14/2024 20:31:03

Evoke Pharma (NASDAQ:EVOK) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.50...

Earnings Scheduled For March 14, 2024
03/14/2024 09:52:13

Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter.

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
03/13/2024 21:32:47

Laurence W. Lytton Reports In 13G Filing A...
03/13/2024 18:02:17

https://www.sec.gov/Archives/edgar/data/1105806/000093583624000282/evok13g.htm

A Preview Of Evoke Pharma's Earnings
03/13/2024 18:02:17

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
02/09/2024 13:06:11

Evoke Pharma Has Priced An Underwritten Pu...
02/09/2024 12:33:00

The offering is comprised of (i) 11,029,411 shares of common stock (or pre-funded warrants in lieu thereof), (ii) 11,029,411 Se...